Surgical Timeline
Endoscopic endonasal surgery. Removed tissue sample for pathology. Surgeons: Dr. Robert Kerr (Neurosurgery), Dr. Sabbir Khan (ENT).
Resection Biopsy, Pituitary AdenomaMajor resection via endoscopic endonasal approach. Surgeons: Dr. Robert Kerr (Neurosurgery), Dr. Sabbir Khan (ENT).
Major Resection, ChordomaTransnasal Dr. William Curry (Neurosurgery), Dr. Stacey Gray (ENT).
📄 View Operative Note (PDF)Left Frontotemporal Craniotomy. Dr. William Curry (Neurosurgery)
📄 View Operative Note (PDF)Left sinonasal/pterygopalatine fossa chordoma. Surgeons: Dr Curry Dr. Stacey Gray
📄 View Operative Note (PDF) (Dr. Stacey Gray) 📄 View Operative Report (PDF) (Dr. William Curry)Endoscopic biopsy and debulking of left middle turbinate mass. Surgeon Dr. Stacey Gray
📄 View Operative Note (PDF)Transnasal Dr. William Curry (Neurosurgery), Dr. Stacey Gray (ENT).
Surgery #1: Biopsy
Endoscopic Endonasal Biopsy
January 15, 2023Hospital: Huntington Hospital
Surgeons: Dr. Robert Kerr (Attending), Dr. SabbirKhan (ENT)
Duration: ___________
Anesthesia: General
Approach: Endoscopic through nasal cavity
Procedure Details
[Pituitary macroadenoma. Surgical Consult Report Final Diagnosis Received from Huntington Hospital, 2 slide(s) and 1 block labeled: 60-S-19-3716. Date of procedure: 03/29/2019. 1. "2. Pituitary mass", excision - Chordoma involving boneDescribe the procedure, what was done, any complications or noteworthy events]
Pre-Op Preparation
- Fasting instructions
- Medications stopped/continued
- Pre-op tests completed
Recovery
- Hospital stay duration 3 days
- Immediate post-op symptoms
- Pain management
- Discharge instructions
Pathology Results
Confirmed: Classic chordoma Final Diagnosis Received from Huntington Hospital, 2 slide(s) and 1 block labeled: 60-S-19-3716. Date of procedure: 03/29/2019. 1. "2. Pituitary mass", excision - Chordoma involving bone, see comment Comment: Immunostains are performed on block 2A and show tumor cells are positive for pancytokeratin AE1/AE3, EMA and S-100 (patchy). Slide(s) with built in immunohistochemical study control(s) and negative control associated with this case has/have been verified by the sign out pathologist
Grade: _____
Margins: _____
Surgery #2: Resection
Tumor Resection
June 14, 2019Hospital: Huntington Hospital
Lead Surgeon: Dr. Robert Kerr (Neurosurgery)
Co-Surgeon: Dr. Sabbir Khan (ENT/Skull Base)
Duration: ___ hours
Anesthesia: General
Surgical Approach
[Describe the approach - Endoscopic endonasal]
Goals of Surgery
- Maximize safe resection of tumor
- Preserve neurological function
- Minimize complications
Outcomes
- Extent of resection (Partial)
- Complications (major Diabetes insipidus, neurohypophyseal Endocrinology Referral Outpatient please evaluate and treat - diabetes insipidus post clival chordoma resection - currently controlled with desmopressin once daily Status: Hold For - Scheduling Requested for: 27Jun2019)
- Neurological status post-op
- ICU stay duration
- Hospital discharge date
Follow-Up Plan
- Radiation therapy planned? No
- Imaging schedule
- Follow-Up @ Mas General Hospital
My Medical Team
| Role | Name | Contact | Notes |
|---|---|---|---|
| Neurosurgeon | Dr. Robert Kerr | _____ | Lead surgeon |
| Neurosurgeon | Dr. William Curry | _____ | Lead surgeon |
| ENT / Skull Base | Dr. Sabbir Khan | _____ | Co-surgeon | ENT / Skull Base | Dr. Stacey Gray | _____ | Co-surgeon |
| MedicalOncologist | Dr. Gregory Cote | _____ | Follow-up care |
| Radiation Oncologist | Dr. Shannon Mcdonald | _____ | RT planning |
| Radiation Oncologist | Dr. Ariel Marciscano | _____ | RT planning |
| Primary Care | Dr. _____ | _____ | Coordination |
Recovery Milestones
Post-Surgery Recovery Tracker
| Milestone | Target Date | Actual Date | Notes |
|---|---|---|---|
| Hospital Discharge | |||
| Walk Independently | |||
| Return to Soft Diet | |||
| Resume Normal Activities | |||
| Return to Work |